Kyowa Kirin Co (STU:KY4) Total Receivables: €993 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:KY4 Kyowa Kirin Co Ltd STU:KY4
85 GF Score
Price €14.30
GF Value €15.89
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Kyowa Kirin Co Total Receivables?

Kyowa Kirin Co STU:KY4 +1.42% 85 Total Receivables is €993 Mil as of Dec. 2025. GuruFocus rates STU:KY4 with a GF Score™ of 85/100 and a GF Value™ of €15.89 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Kyowa Kirin Co's Total Receivables for the quarter that ended in Dec. 2025 was €993 Mil.

Kyowa Kirin Co Total Receivables Related Terms

Kyowa Kirin Co Total Receivables Historical Data

* Premium members only.

The historical data trend for Kyowa Kirin Co's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kyowa Kirin Co Total Receivables Chart

Kyowa Kirin Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 810.69 781.89 758.42 974.87 992.52

Kyowa Kirin Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 847.04 952.35 874.84 992.52 659.03
STU:KY4
85GF Score
Kyowa Kirin Co Ltd STU:KY4
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kyowa Kirin Co Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of €993 Mil mean?
Kyowa Kirin Co (STU:KY4) has a Total Receivables of €993 Mil as of Dec. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Kyowa Kirin Co and its competitors.
Is Kyowa Kirin Co's Total Receivables too high?
Kyowa Kirin Co's current Total Receivables is €993 Mil. Overall, Kyowa Kirin Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kyowa Kirin Co's Total Receivables compare to ZTS and UTHR?
Kyowa Kirin Co's Total Receivables of €993 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Kyowa Kirin Co and its competitors. Kyowa Kirin Co's current Total Receivables is €993 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kyowa Kirin Co stock overvalued right now?
Based on GuruFocus' analysis, Kyowa Kirin Co (STU:KY4) is currently considered Modestly Undervalued. The stock's GF Value™ is €15.89, compared to a current price of €14.30 — trading 10% below its estimated fair value. The current Total Receivables is €993 Mil. Kyowa Kirin Co's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Kyowa Kirin Co (STU:KY4), the current Total Receivables is €993 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kyowa Kirin Co (STU:KY4) Overvalued in 2026?

Based on GuruFocus' analysis, Kyowa Kirin Co stock appears to be undervalued. The current stock price of €14.30 is trading 10% below its estimated GF Value™ of €15.89. GuruFocus considers Kyowa Kirin Co to be Modestly Undervalued.

Key valuation signals for STU:KY4:

  • Total Receivables: €993 Mil
  • GF Value™: €15.89 vs. price of €14.30 (10% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the STU:KY4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kyowa Kirin Co Business Description

Address 1-9-2 Otemachi, Chiyoda-ku, Chiyoda-ku, Tokyo, JPN, 100-0004
Kyowa Kirin Co Ltd is engaged in research, development, manufacturing, sales, import and export of prescription pharmaceuticals. Its products include KHK4083/AMG 451, rocatinlimab; ziftomenib; OTL-203 KK8398, infigratinib; KHK4951, tivozanib; OTL-201; KK4277; KK2260; KK2269; KK2845; and KK8123.
85GF Score

Get the complete analysis for STU:KY4

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.30
Price
€15.89
GF Value